Literature DB >> 12184519

Resource utilization associated with irritable bowel syndrome in the United States 1987-1997.

Ya-Chen Tina Shih1, Victoria E Barghout, Robert S Sandler, Priti Jhingran, Medha Sasane, Suzanne Cook, David C Gibbons, Michael Halpern.   

Abstract

This study uses national databases to examine the impact of irritable bowel syndrome (IBS) on resource utilization in the United States. Approximately 1.5-2.7 million physician visits (599-1,043 per 100,000) yearly were related to IBS, with 45.3% seen by gastroenterologists, and 89% prescribed medications. Rates of physician visits by women were approximately 2.4-3.3 times higher than that for men. The average number of medication prescribed per visit was 1.83. Approximately 89% of the visits were prescribed with medications. The rate of hospitalization (5.1 per 100,000 in 1997) decreased by 60% and length of stay decreased from 5.5 to 3.1 days in the past decade. The average charges of IBS-related hospitalization were US$7,882. Our study found an apparent decreasing trend of IBS-related hospitalizations and no marked increase in office consultations in the past decade. However, a better case identification criterion is necessary to estimate the true disease burden.

Entities:  

Mesh:

Year:  2002        PMID: 12184519     DOI: 10.1023/a:1016471923384

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

Review 1.  Review article: irritable bowel syndrome.

Authors:  M Camilleri; M G Choi
Journal:  Aliment Pharmacol Ther       Date:  1997-02       Impact factor: 8.171

Review 2.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 3.  Irritable bowel syndrome and sexual/physical abuse history.

Authors:  D A Drossman
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-04       Impact factor: 2.566

Review 4.  The challenge of irritable bowel syndrome.

Authors:  P A Bonis; R A Norton
Journal:  Am Fam Physician       Date:  1996-03       Impact factor: 3.292

Review 5.  Irritable bowel syndrome: new pharmaceutical approaches to treatment.

Authors:  M J Farthing
Journal:  Baillieres Best Pract Res Clin Gastroenterol       Date:  1999-10

Review 6.  Irritable bowel syndrome.

Authors:  R B Lynn; L S Friedman
Journal:  N Engl J Med       Date:  1993-12-23       Impact factor: 91.245

Review 7.  Review article: clinical evidence to support current therapies of irritable bowel syndrome.

Authors:  M Camilleri
Journal:  Aliment Pharmacol Ther       Date:  1999-05       Impact factor: 8.171

Review 8.  Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.

Authors:  W G Paterson; W G Thompson; S J Vanner; T R Faloon; W W Rosser; R W Birtwhistle; J L Morse; T A Touzel
Journal:  CMAJ       Date:  1999-07-27       Impact factor: 8.262

9.  Epidemiology of colonic symptoms and the irritable bowel syndrome.

Authors:  N J Talley; A R Zinsmeister; C Van Dyke; L J Melton
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

10.  U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.

Authors:  D A Drossman; Z Li; E Andruzzi; R D Temple; N J Talley; W G Thompson; W E Whitehead; J Janssens; P Funch-Jensen; E Corazziari
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

View more
  10 in total

1.  Trauma history and risk of the irritable bowel syndrome in women veterans.

Authors:  D L White; L S Savas; K Daci; R Elserag; D P Graham; S J Fitzgerald; S L Smith; G Tan; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2010-06-04       Impact factor: 8.171

Review 2.  Frontiers in functional dyspepsia.

Authors:  Noel R Fajardo; Filippo Cremonini; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2005-08

3.  Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals.

Authors:  Raymond Addante; Bruce Naliboff; Wendy Shih; Angela P Presson; Kirsten Tillisch; Emeran A Mayer; Lin Chang
Journal:  J Clin Gastroenterol       Date:  2019-04       Impact factor: 3.062

Review 4.  Costs of irritable bowel syndrome in the UK and US.

Authors:  Stefanie Maxion-Bergemann; Frank Thielecke; Florian Abel; Rito Bergemann
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS.

Authors:  S Ballou; L Keefer
Journal:  Neurogastroenterol Motil       Date:  2016-10-25       Impact factor: 3.598

6.  Meta-analysis: do irritable bowel syndrome symptoms vary between men and women?

Authors:  M A Adeyemo; B M R Spiegel; L Chang
Journal:  Aliment Pharmacol Ther       Date:  2010-07-22       Impact factor: 8.171

Review 7.  New approaches to the medical treatment of irritable bowel syndrome.

Authors:  Driss Berrada; Katia Canenguez; Tony Lembo
Journal:  Curr Gastroenterol Rep       Date:  2003-08

8.  Neuronal Nitric Oxide Synthase Is a Novel Biomarker for the Interstitial Cells of Cajal in Stress-Induced Diarrhea-Dominant Irritable Bowel Syndrome.

Authors:  Da Eun Jang; Ji Hyun Bae; Yoo Jin Chang; Yoon Hoo Lee; Ki Taek Nam; Il Yong Kim; Je Kyung Seong; Yong Chan Lee; Su Cheong Yeom
Journal:  Dig Dis Sci       Date:  2018-01-25       Impact factor: 3.199

Review 9.  Psychosocial impact of irritable bowel syndrome: A brief review.

Authors:  Sarah Ballou; Alyse Bedell; Laurie Keefer
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

10.  Preliminary investigation of the associations between psychological flexibility, symptoms and daily functioning in people with chronic abdominal pain.

Authors:  Lin Yu; Yoram Inspector; Lance M McCracken
Journal:  Br J Pain       Date:  2020-06-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.